Perspective Therapeutics
CATX
26 hedge funds and large institutions have $10.5M invested in Perspective Therapeutics in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 9 closing their positions.
129% more capital invested
Capital invested by funds: $4.58M → $10.5M (+$5.9M)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
4% more funds holding
Funds holding: 25 → 26 (+1)
0.24% more ownership
Funds ownership: 0.38% → 0.62% (+0.24%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$1.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.11M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$358K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$240K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$234K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$496K |
| 2 |
SFSIG
San Francisco Sentry Investment Group
San Francisco,
California
|
-$82K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$78K |
| 4 |
CM
Churchill Management
Los Angeles,
California
|
-$44K |
| 5 |
NES
New England Securities
New York
|
-$44K |
CATX Hedge Fund Activity: Q2 2014 in Review
26 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2014, worth a combined $10.5M — up 129% from $4.58M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CATX positions and 9 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Manatuck Hill Partners, opening a new position worth an estimated $1.5M. The largest seller was Sabby Management, exiting entirely with an estimated $496K sold.
- 26 institutional investors held Perspective Therapeutics (CATX) as of Q2 2014, up from 25 in Q1 2014.
- Funds reported $10.5M of Perspective Therapeutics stock for Q2 2014, up 129% quarter-over-quarter.
- 10 funds opened new Perspective Therapeutics positions in Q2 2014 and 9 closed out, a net change of +1 holder.
- The largest Perspective Therapeutics buyer in Q2 2014 was Manatuck Hill Partners, an estimated $1.5M added.
- The largest Perspective Therapeutics seller in Q2 2014 was Sabby Management, an estimated $496K sold.
Based on aggregated 13F filings for Q2 2014.